ArticleEBioMedicine2024

PAK4-targeted PROTACs in clear cell renal cell carcinoma: a two-for-one targeted and immune therapy?

Ziad Bakouny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.